SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Xylem Inc. – ‘10-Q’ for 6/30/22 – ‘EX-31.1’

On:  Tuesday, 8/2/22, at 11:54am ET   ·   For:  6/30/22   ·   Accession #:  1524472-22-34   ·   File #:  1-35229

Previous ‘10-Q’:  ‘10-Q’ on 5/4/22 for 3/31/22   ·   Next:  ‘10-Q’ on 11/1/22 for 9/30/22   ·   Latest:  ‘10-Q’ on 10/31/23 for 9/30/23   ·   3 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 8/02/22  Xylem Inc.                        10-Q        6/30/22   94:11M

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   2.57M 
 2: EX-10.1     Material Contract                                   HTML     48K 
 3: EX-10.2     Material Contract                                   HTML     57K 
 4: EX-10.3     Material Contract                                   HTML    134K 
 5: EX-31.1     Certification -- §302 - SOA'02                      HTML     29K 
 6: EX-31.2     Certification -- §302 - SOA'02                      HTML     29K 
 7: EX-32.1     Certification -- §906 - SOA'02                      HTML     26K 
 8: EX-32.2     Certification -- §906 - SOA'02                      HTML     26K 
14: R1          Cover Page                                          HTML     82K 
15: R2          Condensed Consolidated Income Statements            HTML    108K 
                (Unaudited)                                                      
16: R3          Condensed Consolidated Statements of Comprehensive  HTML     73K 
                (Loss) Income (Unaudited)                                        
17: R4          Condensed Consolidated Balance Sheets (Unaudited)   HTML    143K 
18: R5          Condensed Consolidated Balance Sheets (Unaudited)   HTML     36K 
                (Parenthetical)                                                  
19: R6          Condensed Consolidated Statements of Cash Flows     HTML    113K 
                (Unaudited)                                                      
20: R7          Background and Basis of Presentation                HTML     32K 
21: R8          Revenue                                             HTML    119K 
22: R9          Restructuring Charges                               HTML    113K 
23: R10         Income Taxes                                        HTML     32K 
24: R11         Earnings Per Share                                  HTML     63K 
25: R12         Inventories                                         HTML     33K 
26: R13         Goodwill and Other Intangible Assets                HTML     66K 
27: R14         Derivative Financial Instruments                    HTML     79K 
28: R15         Accrued and Other Current Liabilities               HTML     36K 
29: R16         Credit Facilities and Debt                          HTML     54K 
30: R17         Post-retirement Benefit Plans                       HTML     63K 
31: R18         Equity                                              HTML    135K 
32: R19         Share-Based Compensation Plans                      HTML     87K 
33: R20         Capital Stock                                       HTML     28K 
34: R21         Accumulated Other Comprehensive Income (Loss)       HTML    116K 
35: R22         Commitments and Contingencies                       HTML     41K 
36: R23         Segment Information                                 HTML     96K 
37: R24         Background and Basis of Presentation (Policies)     HTML     30K 
38: R25         Revenue (Tables)                                    HTML    116K 
39: R26         Restructuring Charges (Tables)                      HTML    115K 
40: R27         Earnings Per Share (Tables)                         HTML     63K 
41: R28         Inventories (Tables)                                HTML     34K 
42: R29         Goodwill and Other Intangible Assets (Tables)       HTML     67K 
43: R30         Derivative Financial Instruments (Tables)           HTML     71K 
44: R31         Accrued and Other Current Liabilities (Tables)      HTML     36K 
45: R32         Credit Facilities and Debt (Tables)                 HTML     44K 
46: R33         Post-retirement Benefit Plans (Tables)              HTML     58K 
47: R34         Equity (Tables)                                     HTML    131K 
48: R35         Share-Based Compensation Plans (Tables)             HTML     94K 
49: R36         Accumulated Other Comprehensive Income (Loss)       HTML    116K 
                (Tables)                                                         
50: R37         Commitments and Contingencies (Tables)              HTML     34K 
51: R38         Segment Information (Tables)                        HTML     91K 
52: R39         Background and Basis of Presentation (Details)      HTML     27K 
53: R40         Revenue - Disaggregation of Revenue (Details)       HTML     84K 
54: R41         Revenue (Details)                                   HTML     43K 
55: R42         Revenue (Narrative) (Details)                       HTML     32K 
56: R43         Restructuring Charges (Textuals) (Details)          HTML     46K 
57: R44         Restructuring Charges (Restructuring Charges)       HTML     46K 
                (Details)                                                        
58: R45         Restructuring Charges (Accrual Rollfoward)          HTML     50K 
                (Details)                                                        
59: R46         Restructuring Charges (Estimated Restructuring      HTML     63K 
                Costs) (Details)                                                 
60: R47         Income Taxes (Textuals) (Details)                   HTML     33K 
61: R48         Earnings Per Share (Calculations for EPS)           HTML     74K 
                (Details)                                                        
62: R49         Earnings Per Share (Summary of Antidilutive         HTML     35K 
                Securities) (Details)                                            
63: R50         Inventories (Details)                               HTML     34K 
64: R51         Goodwill and Other Intangible Assets (Goodwill      HTML     38K 
                Rollforward) (Details)                                           
65: R52         Goodwill and Other Intangible Assets (Summary of    HTML     60K 
                Intangible Assets) (Details)                                     
66: R53         Goodwill and Other Intangible Assets (Details       HTML     28K 
                Textual)                                                         
67: R54         Derivative Financial Instruments (Effect of         HTML     60K 
                Deriative Instruments on Income Statement and                    
                Statement of Comprehensive Income) (Details)                     
68: R55         Derivative Financial Instruments (Balance Sheet     HTML     41K 
                Location of Derivative Instruments) (Details)                    
69: R56         Derivative Financial Instruments (Details Textual)  HTML     71K 
70: R57         Accrued and Other Current Liabilities (Details)     HTML     41K 
71: R58         Credit Facilities and Debt (Summary of Debt         HTML     59K 
                Outstanding) (Details)                                           
72: R59         Credit Facilities and Debt (Textuals) (Details)     HTML     93K 
73: R60         Post-retirement Benefit Plans (Summary of Net       HTML     47K 
                Periodic Benefit Cost) (Details)                                 
74: R61         Post-retirement Benefit Plans (Textuals) (Details)  HTML     43K 
75: R62         Equity - Summary of Shareholders' Equity (Details)  HTML     90K 
76: R63         Share-Based Compensation Plans (Textuals)           HTML     51K 
                (Details)                                                        
77: R64         Share-Based Compensation Plans (Summary of Stock    HTML     75K 
                Options Grant) (Details)                                         
78: R65         Share-Based Compensation Plans (Stock Option Fair   HTML     38K 
                Value Assumptions) (Details)                                     
79: R66         Share-Based Compensation Plans (Summary of          HTML     54K 
                Restricted Stock Unit Grants) (Details)                          
80: R67         Share-Based Compensation Plans Share-Based          HTML     45K 
                Compensation Plans (Summary of ROIC Performance                  
                Share Unit Grants) (Details)                                     
81: R68         Share-Based Compensation Plans (Summary of          HTML     54K 
                Performance-Based Share Grants) (Details)                        
82: R69         Share-Based Compensation Plans (TSR                 HTML     37K 
                Performance-Based Shares Fair Value Assumptions)                 
                (Details)                                                        
83: R70         Share-Based Compensation Plans - Summary of REV     HTML     44K 
                Performance Share Unit Grants (Details)                          
84: R71         Capital Stock (Textuals) (Details)                  HTML     44K 
85: R72         Accumulated Other Comprehensive Income (Loss)       HTML     84K 
                (Details)                                                        
86: R73         Commitments and Contingencies (Summary of           HTML     33K 
                Warranties) (Details)                                            
87: R74         Commitments and Contingencies (Details Textual)     HTML     31K 
88: R75         Segment Information (Summary of Operations by       HTML     74K 
                Segment) (Details)                                               
89: R76         Segment Information (Textuals) (Details)            HTML     26K 
92: XML         IDEA XML File -- Filing Summary                      XML    171K 
90: XML         XBRL Instance -- xyl-20220630_htm                    XML   3.42M 
91: EXCEL       IDEA Workbook of Financial Reports                  XLSX    158K 
10: EX-101.CAL  XBRL Calculations -- xyl-20220630_cal                XML    168K 
11: EX-101.DEF  XBRL Definitions -- xyl-20220630_def                 XML    718K 
12: EX-101.LAB  XBRL Labels -- xyl-20220630_lab                      XML   1.59M 
13: EX-101.PRE  XBRL Presentations -- xyl-20220630_pre               XML   1.08M 
 9: EX-101.SCH  XBRL Schema -- xyl-20220630                          XSD    165K 
93: JSON        XBRL Instance as JSON Data -- MetaLinks              419±   641K 
94: ZIP         XBRL Zipped Folder -- 0001524472-22-000034-xbrl      Zip    497K 


‘EX-31.1’   —   Certification — §302 – SOA’02


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Document  

EXHIBIT 31.1
CERTIFICATION PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Patrick K. Decker, certify that:
1.I have reviewed this Quarterly Report on Form 10-Q of Xylem Inc. for the period ended June 30, 2022;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a)all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 2, 2022
/s/ Patrick K. Decker
President and Chief Executive Officer



Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:8/2/228-K
For Period end:6/30/22
 List all Filings 


2 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/28/24  Xylem Inc.                        10-K       12/31/23  152:19M
 2/24/23  Xylem Inc.                        10-K       12/31/22  143:18M


1 Previous Filing that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/15/17  Xylem Inc.                        8-K:5,9     5/10/17    3:275K
Top
Filing Submission 0001524472-22-000034   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., Apr. 29, 2:20:20.1am ET